Tocilizumab for retinal vasoproliferative tumor secondary to juvenile idiopathic arthritis-associated uveitis: a case report.
Department of Ophthalmology, Hospital Clínic of Barcelona, University of Barcelona, Barcelona, Spain, amadan@clinic.ub.es.
Alfredo
A
Adán
Marina
M
Mesquida
Victor
V
Llorenç
Consuelo
C
Modesto
D000328:Adult; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D001171:Arthritis, Juvenile / Q000150:complications*; D005122:Exudates and Transudates; D005260:Female; D018324:Hemangioma, Capillary / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D019947:Receptors, Interleukin-6 / Q000037:antagonists & inhibitors; D019572:Retinal Neoplasms / Q000188:drug therapy* / Q000209:etiology; D041623:Tomography, Optical Coherence; D014605:Uveitis / Q000150:complications*; D014792:Visual Acuity / Q000502:physiology
D061067:Antibodies, Monoclonal, Humanized; D019947:Receptors, Interleukin-6; C502936:tocilizumab